David F. Mobley, MD

Associate Professor Clinical Urology, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Recent advances in the treatment of erectile dysfunction
Mobley, DF, Khera, M & Baum, N 2017, Postgraduate Medical Journal, vol. 93, no. 1105, pp. 679-685. https://doi.org/10.1136/postgradmedj-2016-134073

Improving operating efficiency with emphasis on prosthetic surgery
Baum, N, Mobley, DF & Perito, P 2015, Asian Journal of Andrology, vol. 17, no. 4, pp. 686-688. https://doi.org/10.4103/1008-682X.142146

Early history of inflatable penile prosthesis surgery: A view from someone who was there
Mobley, DF 2015, Asian Journal of Andrology, vol. 17, no. 2, pp. 225-229. https://doi.org/10.4103/1008-682X.140962

Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment
Mobley, DF, Feibus, A & Baum, N 2015, Postgraduate Medicine, vol. 127, no. 3, pp. 301-307. https://doi.org/10.1080/00325481.2015.1018799

Etiology, evaluation, and management of nocturia in elderly men and women.
Mobley, DF & Baum, N 2014, Postgraduate Medicine, vol. 126, no. 2, pp. 147-153. https://doi.org/10.3810/pgm.2014.03.2751

Urinary symptoms in patients with low back pain
Girard, L, Baum, N & Mobley, DF 2013, Journal of Pain Management, vol. 6, no. 2, pp. 95-103.

Patients with low back pain and urinary symptoms
Girard, L, Baum, N & Mobley, DF 2013, . in Pain: International Research in Pain Management. Nova Science Publishers, Inc. pp. 235-247.

Medical management of benign prostatic hyperplasia in older adults
Mobley, DF & Baum, N 2004, Geriatrics and Aging, vol. 7, no. 6, pp. 23-28.

Long-term safety and efficacy of oral phentolamine mesylate (Vasomax®) in men with mild to moderate erectile dysfunction
Padma-Nathan, H, Goldstein, I, Klimberg, I, Coogan, C, Auerbach, S, Lammers, P, Gleason, D, Young, J, Kaufman, J, Gittelman, M, Knoll, D, Wiatrak, M, Wells, G, Brito, G, Steidle, C, Susset, J, Talley, D, Feldman, R, Murdock, M, Childs, S, Zinner, N, Dula, E, Koukol, S, Knapp, P, Immergut, M, Snyder, J, Kornitzer, G, Belker, A, Barada, J, Byrne, J, Harris, R, McMahon, G, Mobley, DF, Bloom, S, Kidd, D, Tomera, K & Lamm, S 2002, International Journal of Impotence Research, vol. 14, no. 4, pp. 266-270. https://doi.org/10.1038/sj.ijir.3900885

The long-term effect of specific type II 5a-reductase inhibition with finasteride on bone mineral density in men: Results of a 4-year placebo controlled trial
Matsumoto, AM, Tenover, L, McClung, M, Mobley, DF, Geller, J, Sullivan, M, Grayhack, J, Wessells, H, Kadmon, D, Flanagan, M, Zhang, GK, Schmidt, J, Taylor, AM, Lee, M & Waldstreicher, J 2002, Journal of Urology, vol. 167, no. 5, pp. 2105-2108.

Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia
Kaplan, SA, Holtgrewe, HL, Bruskewitz, R, Saltzman, B, Mobley, DF, Narayan, P, Lund, RH, Weiner, S, Wells, G, Cook, TJ, Meehan, A & Waldstreicher, J 2001, Urology, vol. 57, no. 6, pp. 1073-1077. https://doi.org/10.1016/S0090-4295(01)00985-2

Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence
Versi, E, Appell, R, Mobley, DF, Patton, W & Saltzstein, D 2000, Obstetrics and gynecology, vol. 95, no. 5, pp. 718-721. https://doi.org/10.1016/S0029-7844(99)00661-4

Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence
Anderson, RU, Mobley, D, Blank, B, Saltzstein, D, Susset, J & Brown, JS 1999, Journal of Urology, vol. 161, no. 6, pp. 1809-1812. https://doi.org/10.1016/S0022-5347(05)68810-6

When patients request the impotence pill: Tips for office evaluation and treatment
Mobley, DF & Baum, N 1998, Postgraduate Medicine, vol. 104, no. 2, pp. 55-66.

Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasia
Mobley, DF, Dias, N & Levenstein, M 1998, Clinical Therapeutics, vol. 20, no. 1, pp. 101-109. https://doi.org/10.1016/S0149-2918(98)80038-6

Effect of doxazosin on the symptoms of benign prostatic hyperplasia: Results from three double-blind placebo-controlled studies
Mobley, DF, Kaplan, S, Ice, K, Gaffney, M & Dias, N 1997, International Journal of Clinical Practice, vol. 51, no. 5, pp. 282-288.

Doxazosin for benign prostatic hyperplasia: Long-term efficacy and safety in hypertensive and normotensive patients
Lepor, H, Kaplan, SA, Klimberg, I, Mobley, DF, Fawzy, A, Gaffney, M, Ice, K & Dias, N 1997, Journal of Urology, vol. 157, no. 2, pp. 525-530. https://doi.org/10.1016/S0022-5347(01)65193-0

Interstitial cystitis: When urgency and frequency mean more than routine inflammation
Mobley, DF & Baum, N 1996, Postgraduate Medicine, vol. 99, no. 5, pp. 201-214.

The Effect of Zanoterone, a Steroidal Androgen Receptor Antagonist, in Men with Benign Prostatic Hyperplasia
Berger, BM, Naadimuthu, A, Boddy, A, Fisher, HA, McConnell, JD, Milam, D, Mobley, DF & Rajfer, JFTZSG 1995, The Journal of Urology, vol. 154, no. 3, pp. 1060-1064.

Clinical experience with mentor alpha I inflatable penile prosthesis. Report on 333 cases
Randrup, E, Wilson, S, Mobley, DF, Suarez, G, Mekras, G & Baum, N 1993, Urology, vol. 42, no. 3, pp. 305-308.

Live Chat Available